Publications by authors named "Milena Fava"

Claim this Profile
R
Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Daniela Cilloni, Aline Renneville, Fabienne Hermitte, Robert K Hills, Sarah Daly, Milena Fava

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy.
Daniela Cilloni, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Enrico Gottardi, Milena Fava

Haematologica· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular monitoring in patients with chronic myelogenous leukemia.
Giuseppe Saglio, Stefano Ulisciani, Milena Fava, Enrico Gottardi, Daniela Cilloni

Curr Hematol Malig Rep· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
Gisella Volpe, Alessandro Cignetti, Cristina Panuzzo, Mirela Kuka, Katiuscia Vitaggio, Milena Fava

Cancer Res· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, Simona Bassi, Marilina Amabile, Milena Fava

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
Daniela Cilloni, Francesca Messa, Enrico Gottardi, Milena Fava, Francesca Arruga

Cancer· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients.
Daniela Cilloni, Sonia Carturan, Enrico Gottardi, Francesca Messa, Milena Fava

Blood· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.
Daniela Cilloni, Sonia Carturan, Enrico Gottardi, Francesca Messa, Emanuela Messa, Milena Fava

Blood· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.
Daniela Cilloni, Enrico Gottardi, Milena Fava, Francesca Messa, Sonia Carturan

Blood· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.
Daniela Cilloni, Enrico Gottardi, Francesca Messa, Milena Fava, Patrizia Scaravaglio

J Clin Oncol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis